Suchergebnisse - "Fabbri, Chiara"

PubPharm (16)

1

Metabolizing status of CYP2C19 in response and side effects to medications for depression : Results from a naturalistic study

enthalten in: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology | 2022

von Calabrò, M. | Fabbri, C. | Kasper, S. | +11

2

Drug repositioning for treatment-resistant depression : Hypotheses from a pharmacogenomic study

enthalten in: Progress in neuro-psychopharmacology & biological psychiatry | 2021

von Fabbri, C. | Kasper, S. | Zohar, J. | +11

3

Pharmacogenetics and Depression : A Critical Perspective

enthalten in: Psychiatry investigation | 2019

von Corponi, F. | Fabbri, C. | Serretti, A.

4

Corrected QT Interval Prolongation in Psychopharmacological Treatment and Its Modulation by Genetic Variation

enthalten in: Neuropsychobiology | 2019

von Corponi, F. | Fabbri, C. | Boriani, G. | +4

5

Pharmacogenetic tests to guide drug treatment in depression : Comparison of the available testing kits and clinical trials

enthalten in: Progress in neuro-psychopharmacology & biological psychiatry | 2018

von Fabbri, C. | Zohar, J. | Serretti, A.

6

Pleiotropic genes in psychiatry : Calcium channels and the stress-related FKBP5 gene in antidepressant resistance

enthalten in: Progress in neuro-psychopharmacology & biological psychiatry | 2018

von Fabbri, C. | Corponi, F. | Albani, D. | +12

7

Pharmacogenetics in Psychiatry

enthalten in: Advances in pharmacology (San Diego, Calif.) | 2018

von Corponi, F. | Fabbri, C. | Serretti, A.

8

Neuroplasticity and second messenger pathways in antidepressant efficacy : pharmacogenetic results from a prospective trial investigating treatment resistance

enthalten in: European archives of psychiatry and clinical neuroscience | 2017

von Fabbri, C. | Crisafulli, C. | Calati, R. | +11

9

Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance

enthalten in: European archives of psychiatry + clinical neuroscience | 2017

von Fabbri, C. | Crisafulli, C. | Calati, R. | +11

10

Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance

enthalten in: European archives of psychiatry and clinical neuroscience | 2017

von Fabbri, C. | Crisafulli, C. | Calati, R. | +11